Liver transplantation for locally advanced non-resectable intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: early results from the TESLA trial
Br J Surg
.
2025 Mar 4;112(3):znaf054.
doi: 10.1093/bjs/znaf054.
Authors
Sheraz Yaqub
1
2
,
Sondre Busund
1
2
,
Tor Magnus Smedman
3
4
,
Trygve Syversveen
5
,
Ammar Khan
2
4
6
,
Jon Magnus Solheim
2
4
6
,
Trine Folseraas
2
7
8
,
Kristine Wiencke
7
8
,
Kristoffer Lassen
1
9
,
Svein Dueland
4
,
Pål-Dag Line
2
4
6
Affiliations
1
Section of Hepato-Pancreato-Biliary (HPB) Surgery, Department of Gastrointestinal and Paediatric Surgery, Oslo University Hospital, Oslo, Norway.
2
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
3
Department of Oncology, Oslo University Hospital, Oslo, Norway.
4
Transplant Oncology Research Group, Division of Surgery and Specialized Medicine, Oslo University Hospital, Oslo, Norway.
5
Department of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
6
Section for Transplant Surgery, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.
7
Section of Gastroenterology, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.
8
Norwegian PSC Research Centre, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.
9
Institute of Clinical Medicine, the Arctic University of Norway, Tromsø, Norway.
PMID:
40099404
PMCID:
PMC11914714
DOI:
10.1093/bjs/znaf054
No abstract available
Grants and funding
2020067/Regional Health Authority in South-Eastern Norway